Correction: Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement

Stevens, Gretchen A; Alkema, Leontine; Black, Robert E.; Boerma, J. Ties; Collins, Gary S.; Ezzati, Majid; Grove, John; Hogan, Daniel R; Hogan, Margaret C.; Horton, Richard; Lawn, Joy E; Marušić, Ana; Mathers, Colin D.; Murray, Christopher J L; Rudan, Igor; Salomon, Joshua A.; Simpson, Paul J.; Vos, Theo; Welch, Vivian

doi:10.1371/journal.pmed.1002116

Cited by 24 publications

(15 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, a manual search of the reference lists of the related articles was also performed, as well as the references of previous systematic reviews in the world were reviewed [ 17 , 18 ]. This review was performed in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement issued in 2009 [ 19 ] and the GATHER guideline [ 20 ] (Fig. 1 ).…”

Section: Methodsmentioning

confidence: 99%

National, regional, and global prevalence of cigarette smoking among women/females in the general population: a systematic review and meta-analysis

Jafari

Rajabi

Gholian-Aval

et al. 2021

Environ Health Prev Med

View full text Add to dashboard Cite

Background This systematic and meta-analysis review aimed to provide an updated estimate of the prevalence of ever and current cigarette smoking in women, in geographic areas worldwide, and demonstrate a trend of the prevalence of smoking over time by using a cumulative meta-analysis. Methods Following PRISMA guidelines, we conducted a systematic review and meta-analysis of studies published on the prevalence of ever and current cigarette smoking in women. We searched PubMed, Web of Science (ISI), Scopus, and Ovid from January 2010 to April 2020. The reference lists of the studies included in this review were also screened. Data were reviewed and extracted independently by two authors. A random effects model was used to estimate the pooled prevalence of ever and current cigarette smoking in women. Sources of heterogeneity among the studies were determined using subgroup analysis and meta-regression. Results The pooled prevalence of ever and current cigarette smoking in women was 28% and 17%, respectively. The pooled prevalence of ever cigarette smoking in adolescent girls/students of the school, adult women, pregnant women, and women with the disease was 23%, 27%, 32%, and 38%, respectively. The pooled prevalence of ever cigarette smoking in the continents of Oceania, Asia, Europe, America, and Africa was 36%, 14%, 38%, 31%, and 32%, respectively. Conclusions The prevalence of cigarette smoking among women is very high, which is significant in all subgroups of adolescents, adults, and pregnant women. Therefore, it is necessary to design and implement appropriate educational programs for them, especially in schools, to reduce the side effects and prevalence of smoking among women.

show abstract

Section: Methodsmentioning

confidence: 99%

National, regional, and global prevalence of cigarette smoking among women/females in the general population: a systematic review and meta-analysis

Jafari

Rajabi

Gholian-Aval

et al. 2021

Environ Health Prev Med

View full text Add to dashboard Cite

show abstract

“…The present study use data from the second data collection (survey-based project in the section described above), where data on personality were gathered at the same time with emotional distress and metacognitions. Following the guidelines of Strengthening the Reporting of Observational Studies in Epidemiology ( Von Elm et al, 2007 ), and the health estimate reporting standards laid out in the GATHER statement ( Stevens et al, 2016 ), this study was preregistered before any data collection, which can be derived from ClinicalTrials.gov (identifier NCT04444505). The data were collected between June 22 and July 13, 2020, a period approximately 1 week after the major viral mitigation protocols were lifted in Norway and where the national viral mitigation protocols and guidelines were held constant.…”

Section: Methodsmentioning

confidence: 99%

Trait Versus State Predictors of Emotional Distress Symptoms

et al. 2022

View full text Add to dashboard Cite

To enhance formulation and interventions for emotional distress symptoms, research should aim to identify factors that contribute to distress and disorder. One way to formulate emotional distress symptoms is to view them as state manifestations of underlying personality traits. However, the metacognitive model suggests that emotional distress is maintained by metacognitive strategies directed by underlying metacognitive beliefs. The aim of the present study was therefore to evaluate the role of these factors as predictors of anxiety and depression symptoms in a cross-sectional sample of 4936 participants collected during the COVID-19 pandemic. Personality traits (especially neuroticism) were linked to anxiety and depression, but metacognitive beliefs and strategies accounted for additional variance. Among the predictors, metacognitive strategies accounted for the most variance in symptoms. Furthermore, we evaluated two statistical models based on personality traits versus metacognitions and found that the latter provided the best fit. Thus, these findings indicate that emotional distress symptoms are maintained by metacognitive strategies that are better accounted for by metacognitions compared with personality traits. Theoretical and clinical implications of these findings are discussed.

show abstract

“…Epidemiology (STROBE; Von Elm et al, 2007), and the health estimate reporting standards laid out in the GATHER-statement (Stevens et al, 2016), this study was designed and pre-registered prior to any data collection. The pre-registered protocol can be found at ClinicalTrials.gov (Identifier: NCT04442360).…”

Section: Following the Guidelines Of Strengthening The Reporting Of Omentioning

confidence: 99%

Information Dissemination and the COVID-19 Pandemic: The Relationship between Different Information Sources and Symptoms of Psychopathology

Om¹,

Hoffart²,

Su³

et al. 2021

Preprint

View full text Add to dashboard Cite

The 2020-2021 COVID-19 pandemic has added to the mental health strain on individuals and groups across the world. Viral mitigation protocols and viral spread affect millions every day, but to widely different degrees. How individuals gather information about the pandemic might have an effect on levels of mental distress in the population. In this cross-sectional and representative study of the adult population of Norway, findings suggest that information gathered through newspapers and social media are the information pathways with the strongest association to symptoms of anxiety, depression and health anxiety with small to medium effect sizes. However, avoiding information about the pandemic had larger effect sizes related to symptoms of psychopathology than acquiring information about the pandemic from any source. The results suggest that to reach those who avoid pandemic news is an important goal, both to ensure the population as a whole gets relevant information regarding current viral mitigation protocols, that may in turn alleviate stress, and thus reduce the likelihood of viral transmission. The spread of pandemic misinformation on social media and the internet must be buffered, and successful interventions against misinformation may affect the mental health of the population.

show abstract

Correction: Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement

Cited by 24 publications

References 1 publication

National, regional, and global prevalence of cigarette smoking among women/females in the general population: a systematic review and meta-analysis

National, regional, and global prevalence of cigarette smoking among women/females in the general population: a systematic review and meta-analysis

Trait Versus State Predictors of Emotional Distress Symptoms

Information Dissemination and the COVID-19 Pandemic: The Relationship between Different Information Sources and Symptoms of Psychopathology

Contact Info

Product

Resources

About